Get the Stockscreener App
1.81
7.74%
0.13
Pre-market:
1.73
-0.08
-4.42%
Q 32 Bio Inc stock is traded at $1.81, with a volume of 167.75K.
It is up +7.74% in the last 24 hours and down -31.95% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$1.68
Open:
$1.68
24h Volume:
167.75K
Relative Volume:
0.14
Market Cap:
$22.08M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.18%
1M Performance:
-31.95%
6M Performance:
-32.46%
1Y Performance:
-94.92%
1-Day Range:
$1.67
$1.84
1-Week Range:
$1.5685
$2.0799
52-Week Range:
$1.345
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.81 | 20.49M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Using fundamentals and technicals on Q32 Bio Inc.July 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser
Using portfolio simulators with Q32 Bio Inc. includedMarket Growth Report & Fast Momentum Stock Entry Tips - Newser
Is Q32 Bio Inc. stock bottoming outGap Up & Daily Oversold Bounce Ideas - Newser
How to use Fibonacci retracement on Q32 Bio Inc.Weekly Investment Summary & Real-Time Buy Zone Alerts - Newser
Using data tools to time your Q32 Bio Inc. exitJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
What earnings revisions data tells us about Q32 Bio Inc.Trade Entry Report & Real-Time Stock Movement Alerts - Newser
Will Q32 Bio Inc. rebound enough to break even2025 Market Outlook & Weekly High Momentum Picks - Newser
Chart based analysis of Q32 Bio Inc. trendsWeekly Trade Recap & Fast Entry High Yield Tips - Newser
Will Q32 Bio Inc. outperform tech stocks2025 Price Targets & Weekly Hot Stock Watchlists - classian.co.kr
Will a bounce in Q32 Bio Inc. offer an exit2025 Dividend Review & Risk Managed Investment Strategies - Newser
Can trapped investors hope for a rebound in Q32 Bio Inc.Volume Spike & Free Daily Entry Point Trade Alerts - Newser
Q32 Bio Inc. stock outlook for YEAR [July 2025 Selloffs]Free Weekly Return Optimization Plans - Newser
Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Eastern Progress
Should you wait for a breakout in Q32 Bio Inc.Free Triple Return Setup with Risk Control - Newser
Long term hold vs stop loss in Q32 Bio Inc.Free News Based Entry Opportunity Alerts - Newser
Q32 Bio Inc. stock outlook for YEARMarket Ready Picks with Technical Support - Newser
Does Q32 Bio Inc. qualify in momentum factor screeningFree AI Screening for Swing Trade Picks - Newser
Can a trend reversal in Q32 Bio Inc. lead to recoveryFree Trade Scanner With Buy Zone Alerts - Newser
How Q32 Bio Inc. stock reacts to Fed policy changesSwing Trade Entry and Exit Point Analysis - Newser
Will Q32 Bio Inc. benefit from rate cutsTop Fast Growth Opportunities - thegnnews.com
Understanding Q32 Bio Inc.’s price movementTrend Reversal Watch with Entry Signals - Newser
Historical volatility pattern of Q32 Bio Inc. visualizedVolume Based Swing Signal Prediction Map - Newser
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts - TipRanks
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Q32 Bio: Q2 Earnings Snapshot - Stamford Advocate
Q32 Bio August 2025 slides: Bempikibart shows durable response in alopecia areata - Investing.com
Q32 Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q32 Bio Reports Q2 GAAP EPS of -$0.78, Cash Reserves Sufficient for Operations into 2027 - AInvest
Q32 Bio Inc. SEC 10-Q Report - TradingView
Q32 Bio Secures FDA Fast Track for Alopecia Treatment as Phase 2 Trial Advances with $54.8M Runway - Stock Titan
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Q 32 Bio Inc Stock (QTTB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Oct 11 '24 |
Option Exercise |
3.12 |
4,574 |
14,271 |
17,874 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 08 '24 |
Option Exercise |
3.12 |
13,300 |
41,496 |
13,300 |
1.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):